Orthocell (ASX:OCC) said today that its CelGro collagen medical device won CE Mark approval for a range of dental bone and soft tissue regeneration procedures.
The company said it’s in talks with the strategic commercial partners to distribute its product throughout Europe and other key regions. Orthocell is also reportedly holding discussions with key opinion leaders in the dental and bone regeneration fields.
Get the full story at our sister site, Drug Delivery Business News.
The post Orthocell wins CE Mark for CelGro device appeared first on MassDevice.
from MassDevice http://ift.tt/2zFP5mp
Cap comentari:
Publica un comentari a l'entrada